New Issue: Helix BioPharma wraps C$5.52 million private placement of stock

By Sheri Kasprzak

New York, Nov. 7 - Helix BioPharma Corp. said it has concluded a private placement for C$5,523,750.

The company issued 3,156,428 shares at C$1.75 each to European investors.

The investors also received warrants for 3,156,428 shares, exercisable at C$2.45 each through March 31, 2008.

Proceeds will be used for the pre-clinical and clinical development of products in the company's pipeline, as well as for working capital and general corporate purposes.

Based in Aurora, Ont., Helix is a biopharmaceutical company focused on treatments for cancer.

Issuer:	Helix BioPharma Corp.
Issue:	Stock
Amount:	C$5,523,750
Shares:	3,156,428
Price:	C$1.75
Warrants:	For 3,156,428 shares
Warrant expiration:	March 31, 2008
Warrant strike price:	C$2.45
Settlement date:	Nov. 7
Stock price:	C$4.45 at close Nov. 7

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.